Načítá se...
Successful treatment for sorafenib-induced liver dysfunction: a report of case with liver biopsy
Sorafenib is an oral multikinase inhibitor with anti-proliferative and anti-angiogenic effects and is used worldwide for the treatment of advanced or metastatic hepatocellular carcinoma (HCC). While the significant survival benefit of sorafenib in patients with advanced HCC was demonstrated, various...
Uloženo v:
| Vydáno v: | Surg Case Rep |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4713402/ https://ncbi.nlm.nih.gov/pubmed/26943680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40792-016-0131-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|